Victoza® (liraglutide) – Expanded indication
June 17, 2019 - The FDA announced the approval of Novo Nordisk’s Victoza (liraglutide), as an adjunct to diet and exercise to improve glycemic control in patients 10 years and older with type 2 diabetes mellitus (T2DM).
Download PDF
